Loratadine Clinical Trials On General Hives Suggested By NDAC Members
This article was originally published in The Tan Sheet
Executive Summary
An OTC switch of Schering-Plough's non-sedating antihistamine Claritin for general hives would require data from an evidence-based study of acute urticaria, Jesse Joad, MD, UC-Davis Medical Center, asserted at a meeting of FDA's Nonprescription Drugs Advisory Committee April 22